Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Research: Citi Says Apsara Conference Showcases Accelerating AI Momentum, Maintains Buy on Alibaba With USD190... (AAStocks) +++ ALIBABA ADR Aktie -3,24%

CYPHERPUNK Aktie

 >CYPHERPUNK Aktienkurs 
3.57 EUR    +8.8%    (TradegateBSX)
Ask: 3.65 EUR / 829 Stück
Bid: 3.57 EUR / 863 Stück
Tagesumsatz: 199 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
CYPHERPUNK Aktie über LYNX handeln
>CYPHERPUNK Performance
1 Woche: +68,4%
1 Monat: +192,2%
3 Monate: +435,1%
6 Monate: +403,9%
1 Jahr: +1,0%
laufendes Jahr: +201,9%
>CYPHERPUNK Aktie
Name:  CYPHERPUNK TECHNOLOGIES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US52187K2006 / A3EMJP
Symbol/ Ticker:  5MC (Frankfurt) / CYPH (NASDAQ)
Kürzel:  FRA:5MC, ETR:5MC, 5MC:GR, NASDAQ:CYPH
Index:  -
Profil:  Cypherpunk Technologies Inc. is a privacy technology company and digital asset treasury business focused on Zcash. The company is engaged in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies, with a core em..
>Volltext..
Marktkapitalisierung:  320.26 Mio. EUR
Unternehmenswert:  313.6 Mio. EUR
Umsatz:  -
EBITDA:  -15.54 Mio. EUR
Nettogewinn:  -0.77 Mio. EUR
Gewinn je Aktie:  0.53 EUR
Schulden:  0.03 Mio. EUR
Liquide Mittel:  6.66 Mio. EUR
Operativer Cashflow:  -18.41 Mio. EUR
Bargeldquote:  4.39
Umsatzwachstum:  -
Gewinnwachstum:  98.62%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel 1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 30.092 Euro.
Suchwörter:  CYPHERPUNK, LEAP THERAPEUTICS
Letzte Datenerhebung:  23.09.26
>CYPHERPUNK Kennzahlen
Aktien/ Unternehmen:
Aktien: 107.76 Mio. St.
Frei handelbar: 84.76%
Leerverk. Aktien: -
Rückkaufquote: -34.56%
Mitarbeiter: 6
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Strong buy
Kursziel: 9.85%
Bewertung:
KGV: 6.56
KGV lG: -
KUV: -
KBV: 2.87
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -1.08%
Eigenkaprendite: -1.21%
>CYPHERPUNK Peer Group
Gesundheit, Antikörper- Behandlung, Onkologie/ Krebs- Behandlung
 
22.09.26 - 13:03
Cypherpunk Technologies Appoints Amanda Fabiano to Board of Directors (PR Newswire)
 
Veteran mining executive brings operational depth from Nakamoto, TeraWulf, Galaxy, and Fidelity as Cypherpunk launches 4.2 GSol/s Zcash mining fleet Cypherpunk Mining generated 3,023.13 ZEC in first weeks of operation; Added to Treasury CAMBRIDGE, Mass., Sept. 22, 2026 /PRNewswire/ --......
28.08.26 - 01:02
Insiderhandel: Aufsichtsrat verkauft Aktien von Cypherpunk Technologies im Wert von 34400 USD (Insiderkauf)
 
Dietz, Thomas John - Aufsichtsrat - Tag der Transaktion: 2026-08-26...
24.08.26 - 22:27
Cypherpunk Technologies advances 18%, posting yet another double-digit rise (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.08.26 - 13:03
Cypherpunk Technologies Launches World′s Largest Zcash Mining Fleet (PR Newswire)
 
Equity-based transaction with Winklevoss Capital activates 4.2 GSol/s of live, U.S.-based hashrate; approximately 18% of the Zcash network; Industry veteran Kevin Zhang joins as Head of Mining CAMBRIDGE, Mass., Aug. 18, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH)......
12.08.26 - 13:12
Cypherpunk Technologies GAAP EPS of $0.18 beats by $0.21 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.08.26 - 13:06
Cypherpunk Technologies Reports Second Quarter 2026 Financial Results (PR Newswire)
 
CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026. "In the second quarter, Cypherpunk built upon the momentum established earlier this year through the......
12.08.26 - 13:03
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research (PR Newswire)
 
Peer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab......
01.07.26 - 18:00
Forward Industries, Cypherpunk initiated with Buy-equivalent at Cantor (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.05.26 - 13:18
Cypherpunk Technologies GAAP EPS of -$0.46 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.05.26 - 13:06
Cypherpunk Technologies Reports First Quarter 2026 Financial Results (PR Newswire)
 
CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026. "Since the start of 2026, Cypherpunk has advanced the mission to become a leading privacy technology......
15.04.26 - 18:24
Cypherpunk Increases its Zcash Stake, Launches New Website and Investor Dashboard (PR Newswire)
 
CAMBRIDGE, Mass., April 15, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) today announced its latest purchase of 9,163.32 ZEC for $2,150,000 at an average purchase price of $234.63 per ZEC and launched its new website and investor dashboard at cypherpunk.com.......
31.03.26 - 02:01
Insiderhandel: Aufsichtsrat verkauft Aktien von Cypherpunk Technologies im Wert von 42630 USD (Insiderkauf)
 
Miraelli, Christopher - Aufsichtsrat - Tag der Transaktion: 2026-03-26...
17.03.26 - 16:06
Cypherpunk Technologies GAAP EPS of $0.07 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.03.26 - 21:54
Cypherpunk Reports Full Year 2025 Financial Results (PR Newswire)
 
CAMBRIDGE, Mass., March 16, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ("Cypherpunk"), today reported financial results for the year ended December 31, 2025. "2025 was a transformational year. Following a $58.88 million private placement led by Winklevoss Capital,......
09.03.26 - 14:21
Cypherpunk Makes $5M Investment into Zcash Open Development Lab (ZODL) (PR Newswire)
 
Cypherpunk expands its holdings with new $5M investment in Zcash company, ZODL, alongside key investors including a16z, Winklevoss Capital, Coinbase, Paradigm, Chapter One, David Friedberg, Balaji Srinivasan, and others CAMBRIDGE, Mass., March 9, 2026 /PRNewswire/ -- Cypherpunk......
24.02.26 - 10:36
Bitcoin: "Womöglich haben wir in ein paar Monaten das nächste Rekordhoch" (Die Zeit)
 
Es gibt gute Gründe, dass sich der Bitcoin-Kurs wieder erholt, sagt der Urvater der Technik, Adam Back. Wie der Cypherpunk den jüngsten Bitcoin-Einbruch erklärt....
22.01.26 - 13:12
Cypherpunk Adds Arjun Khemani as Strategic Advisor (PR Newswire)
 
CAMBRIDGE, Mass., Jan. 22, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), the privacy technology company, today announced that Arjun Khemani has joined the company as a Strategic Advisor. Khemani, a prominent voice in the Zcash ecosystem and the......
08.01.26 - 15:54
Antanas Guoga: Antanas Guoga Announces Filing of Early Warning Report Related to Sol Strategies Inc. (Newsfile)
 
Toronto, Ontario--(Newsfile Corp. - January 8, 2026) - Antanas Guoga, Chair and director of Sol Strategies Inc. (formerly, Cypherpunk Holdings Inc., the "Company"), announces that he has filed an ......
12.11.25 - 14:02
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results (PR Newswire)
 
CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc. (Nasdaq:LPTX), a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash, today reported......
20.10.25 - 13:03
Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025 (PR Newswire)
 
Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high population Increasing DKK1 levels further improved PFS, OS, and ORR advantage for the Sirexatamab Arm Leap to continue supporting development of sirexatamab in DKK1-high CRC patients CAMBRIDGE,......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Mensch ist reich genug, um sich die eigene Vergangenheit zurückkaufen zu können. - Oscar Wilde
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!